All treatments
Treatment
Biomarker Analysis clinical trials
2 indexed studies · 1 currently recruiting
- Active not recruiting
A Study of miRNA 371 in Patients With Germ Cell Tumors
This study looks at a special marker called miRNA 371 in blood tests for people with germ cell tumours. The aim is to see if this marker can help predict if the cancer might return, allowing doctors to better understand and manage the risk.
For: Germ Cell Tumor · Metachronous Malignant Neoplasm · SeminomaUnited States · Canada · Guam - Enrolling by invitation
Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors
This study aims to understand why anti-cancer drugs called kinase inhibitors have different side effects in people. By looking at genes and blood markers, researchers hope to predict who might have unwanted reactions or not respond well to treatment, especially for breast cancer.
For: CDK4/6 Inhibitor · Breast Cancer · CYP3A4 Protein, HumanCanada